Stockreport

Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock [Yahoo! Finance]

Cognition Therapeutics, Inc.  (CGTX) 
PDF stage company developing product candidates designed to treat neurodegenerative disorders, today announced that it has priced an underwritten public offering of 6,571,42 [Read more]